Prof Iman Osman #melanoma #immunotherapy expert @ #NYU #LangoneCancerCenter attacks an unanswered question. What to do with #NF1 mutant melanoma? Great-DO NOT POST DATA #EGFR #BRAF / #BRIDGE2024 #Vivenko @sitcancer.bsky.social @melanomaresearch.bsky.social #FinishCancer #ChilesResearchInstitute

💥It has started! Day 2 of #melanoma #Bridge2024 Drs. Blank @nkinl.bsky.social Postow @mskcancercenter.bsky.social Osman @csmapnyu.org Ernstoff @ #NCI Levesque #Vivenko @pascierto

On @Delta & enroute 2 #Napoli for #immunotherapy & #melanoma “Bridge” where Dr Paolo Ascierto brings global #immuno-#oncology together/ Looking forward to some fantastic talks & great debates vivenko.net/files/bridge-p… @sitcancer.bsky.social #FinishCancer #Vivenko @chrystalpaulos.bsky.social